Muscle wasting and increased circulating levels of inflammatory cytokines, including tumor necrosis factor alpha (TNF ) are common features of COPD. To investigate if inflammation of the lung is responsible for systemic inflammation and muscle wasting, we adopted a mouse model of pulmonary inflammation resulting from directed over-expression of a TNF transgene controlled by the surfactant protein C (SP-C) promoter. Compared to wild type, SP-C/TNF mice exhibited increased levels of TNF in the circulation and increased endogenous TNF expression in skeletal muscle, potentially reflecting an amplificatory response to circulating TNF . Decreased muscle and body weights observed in SP-C/TNF mice were indicative of muscle wasting. Further evaluation of the SP-C/TNF mouse musculature revealed a decreased muscle regenerative capacity, evidenced by attenuated myoblast proliferation and differentiation in response to reloading of disuse-atrophied muscle, which may contribute to skeletal muscle wasting. Importantly, incubation of cultured myoblasts with TNF also resulted in elevated TNF mRNA levels and inhibition of myoblast differentiation.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a slowly progressive condition characterized by irreversible airflow obstruction associated with an abnormal inflammatory response of the lung (1) . Loss of body and muscle weight in COPD (pulmonary cachexia) significantly contributes to skeletal muscle weakness, impaired exercise capacity, decreased health status and increased mortality independently of primary organ failure (2, 3) . Besides inflammation of the diseased lung (4), pulmonary cachexia is accompanied by increased levels of circulating inflammatory cytokines (5, 6, 7 ) , suggesting that systemic inflammation could trigger or contribute to muscle atrophy. In fact, studies in experimental models revealed that administration of the inflammatory cytokine Tumor Necrosis Factor alpha (TNF ) is sufficient to induce muscle atrophy, demonstrating a causal role for this cytokine in inflammation-associated muscle wasting (8, 9) . However, whether inflammation-associated muscle atrophy also involves inflammatory signaling and gene expression in skeletal muscle is still unclear. Recently, muscle specific activation of Nuclear Factor kappa B (NF-B), a transcription factor required to activate an array of TNF -dependent responses, was shown to be sufficient to induce muscle atrophy in mice, supporting the notion that inflammatory signaling in skeletal muscle results in atrophy (10) . The loss of muscle mass in these mice was the result of a net increase in protein degradation, although in models of systemic inflammation, muscle atrophy has also been associated with decreased muscle protein synthesis (11) . In addition to an inequity in muscle protein synthesis and degradation, an impaired ability to regenerate skeletal muscle may contribute to muscle atrophy.
Muscle regeneration occurs constantly during normal muscle use (12) , but is increased in response to muscle damage, increased muscle load, or resumed muscle use following inactivity 3 (13) . The recruitment of a reservoir of muscle precursor cells named satellite cells is essential for this process. Upon activation satellite cells are stimulated to proliferate (and are called myoblasts at this stage), followed by exit from the cell cycle to engage in the myogenic differentiation program (13) . Impaired satellite cell function as a result of interference with their ability to proliferate, differentiate or fuse could ultimately result in loss of skeletal muscle tissue. We and others have demonstrated previously that myoblast differentiation and fusion are inhibited in response to inflammatory stimuli including TNF (14) (15) (16) , but the relevance of these findings for inflammation-associated muscle atrophy and impaired muscle plasticity remained to be addressed.
In this study we investigated whether chronic pulmonary inflammation results in muscle atrophy and affects muscle regenerative capacity, and whether this is associated with increased circulating and muscle cytokine levels. Mice expressing a TNF transgene under the control of the surfactant protein-C (SP-C) promoter (SP-C/TNF mice) have marked chronic pulmonary inflammation (17, 18) . We specifically evaluated whether the presence of inflammatory mediators extended beyond the pulmonary compartment to the circulation and skeletal muscle tissue, and determined whether SP-C/TNF mice displayed evidence of muscle atrophy and impaired muscle regeneration.
MATERIALS AND METHODS

Animals
All protocols and procedures involving mice were approved by the University of Vermont Institutional Animal Care and Use Committee. SP-C/TNF transgenic mice (Tg-10 line), generated by Dr. Y. Miyazaki (17) were kindly provided by Dr. R. Mason (Department of Medicine, National Jewish Medical and Research Center, Denver, CO) were crossed with C57BL/6 (Jackson Laboratories, Bar Harbor, ME). Offspring was genotyped via PCR analysis as previously described (17) with a slight adaptation in that a second primer pair was added to amplify a 183 bp fragment of the myosin heavy chain perinatal (MyHC-p) gene as an internal control of the PCR reaction to exclude false negative results (forward 5' GAGGAGCGGGCTGACATC 3' and reverse 5' ACCCAGAGAGGCAAGTGACC 3'). Animals were housed in filtertop cages in a temperature controlled room on a 12:12h light-dark cycle with food pellets and water provided ad libitum. For experiments, 18 weeks old male transgenic mice were compared to age-matched transgene negative littermates.
To study potential differences in skeletal muscle plasticity between WT and SP-C/TNF mice, the animals were subjected to hind limb unloading (HU) as described previously (16) . This model causes atrophy of the postural muscles, and subsequent reloading (RL) of the hind limbs evokes muscle regeneration, resulting in the restoration of muscle mass (19) . Transgene positive (Tg+) and wild type (WT) mice were randomly assigned to one of the following groups: baseline (n=12 of each genotype); HU for 14 days (n=8); HU followed by RL for 3, 5, 7, (n=4) or 14 days (n= 8). Following the experimental procedures, mice were euthanized by halothane overdose, body weight and length was determined, and blood was collected from the abdominal aorta. Soleus, gastrocnemius and plantaris muscles were collected using standardized dissection methods, weighed, and frozen in liquid nitrogen. Tibia length was also measured to control for potential developmental or post-natal effects of the transgene on growth. In a subset of experiments, animals received intra-muscular injections in the gastrocnemius/plantaris/soleus area of PBS or TNF (40µg/kg, dissolved in PBS with a final volume of 50µl administered using a 30 gauge needle) every 24h for 5 days. The dose of TNF used here is in the concentration range known to affect skeletal muscle (16, 20) . Muscles were excised 24h following the last injection.
Brochoalveolar lavage
After halothane overdose the chest cavity was opened and the heart, lungs and trachea were dissected as a whole. This procedure also allowed confirmation of the genotype of each animal, as the lungs of transgenic animals have a distinct orange color (17, 18) . Next, a tracheal tube was inserted, fixed and the lungs were lavaged with 1ml saline. The recovered BAL fluid was centrifuged (5', 1000x g at 4°C) and the supernatant was stored at -80°C.
ELISA
The concentrations of TNF , sTNF-RI and sTNF-RII were determined in BAL fluid and serum by ELISA. TNF was detected and quantified using the DuoSet ELISA kit for mouse TNF (R&D Systems, Minneapolis, MN, USA) according to manufacturers' instructions. sTNF-R concentrations were assessed as described previously (21) using reagents kindly provided by Dr.
Buurman (Dept of Surgery, Maastricht University).
Cell culture
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The murine skeletal muscle cell line C2C12 (ATCC# CRL1772, Manassas, VA) was cultured in growth media (GM), composed of low glucose Dulbecco's Modified Eagle Medium (DMEM) containing antibiotics (50U/ml Penicillin and 50µg/ml Streptomycin) and 9% (v/v) Fetal Bovine Serum (FBS) (all from Life Technologies, Rockville, MD), or differentiation media (DM), which contained DMEM with 1% heat-inactivated FBS and antibiotics (DM). Both cell types were grown on Matrigel (Becton Dickinson Labware, Bedford, MA) coated (1:50 in DMEM) dishes as described previously (22) . Cells were plated at 10 4 /cm 2 and cultured in GM for 24h, before induction of differentiation. When applicable, 10ng/ml murine TNF (Calbiochem, La Jolla, CA)
was added once to the culture dishes directly after induction of differentiation, or to fully (5 day) differentiated myotubes.
RNA isolation and assessment of mRNA abundance
At Ribonuclease Protection Assay (RPA) was performed to determine MyoD, myogenin, Troponin-I fast, muscle creatine kinase (MCK), myoglobin, or MyHC-p mRNA levels as previously described (16), using templates developed in our laboratory. Briefly, a radio-labeled multi-probe panel was prepared by transcription reaction using the MaxiScript Kit (Ambion, Houston, TX)
followed by hybridization with 10 or 2µg RNA (8 x10 4 CPM per probe) per sample at 42°C for 18h. The protection reaction was performed by RNase digestion (1:100 diluted RNase A/RNase T1 cocktail) using the RPA III kit (Ambion, Houston, TX), and protected fragments were resolved on a 5% denaturing polyacrylamide gel. Gels were dried and exposed to film (Biomax MR-1, Kodak), or an imaging screen for quantification in a Personal Molecular Imager FX (BioRad, Hercules, CA), and band intensity was analyzed using Quantity One software (Bio-Rad).
Semi-quantitative RT-PCR was used to assess TNF mRNA levels. Total RNA was isolated as indicated above and 1µg was reverse transcribed to cDNA using Superscript II RT and oligo dT primers (Invitrogen, Carlsbad, CA) according to manufacturers' instructions. PCR reactions were performed using Platinum Supermix (Invitrogen). Total TNF (transgenic and endogenous) was instructions.
Statistical analysis
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Raw data was entered into SPSS (version 11.0) for statistical analysis. Values as expressed in the graphs were subjected to one-way analysis of variance, and the various treatment groups were compared post-hoc with a LSD test (P<0.05).
RESULTS
Increased TNF and sTNF-RII in lungs and circulation of SP-C/TNF mice
SP-C/TNF mice exhibit chronic pulmonary inflammation resulting from local expression of a TNF transgene (17, 18) . Assessment of TNF in the broncho-alveolar lavage (BAL) fluid by ELISA confirmed the continuous production of TNF in the lungs of transgene positive (Tg+) mice ( Figure 1A ). The TNF concentration was increased 6-fold in the BAL fluid of Tg+ animals, compared to wild type (WT) littermates, whereas the sTNF-RI concentration in the BAL fluid did not differ between these groups (Tg+: 29.1 ± 3.5 vs WT: 29.4 ± 3.1 pg/ml, respectively).
However, sTNF-RII levels were raised ~2-fold in the BAL fluid of Tg+ mice compared to WT littermates ( Figure 1A ).
TNF and its soluble receptors were also assessed in serum. In line with observations in the BAL fluid, sTNF-RI concentration was not different in serum of Tg+ and WT mice (1.10 ± 0.18 vs 1.09 ± 0.11 ng/ml, respectively), while sTNF-RII levels were increased ~50% in the serum of Tg+ mice ( Figure 1B) . Importantly, no circulating TNF could be detected in any of the WT animals, whereas TNF was clearly detectable in the serum of most Tg+ animals ( Figure 1B ).
Increased TNF expression in skeletal muscle of SP-C/TNF mice
To assess whether the elevated circulating levels of TNF also affected skeletal muscle, endogenous TNF mRNA abundance was determined in muscle tissue by RT-PCR. In gastrocnemius (Figure 2A ), plantaris and soleus muscle (not shown) of Tg+ animals, endogenous TNF mRNA levels were increased 5 to 10 fold compared to WT mice.
To verify whether TNF is capable of inducing its own expression in skeletal muscle, mice were subjected to intramuscular (IM) injections with TNF . Compared to PBS, IM injections with TNF resulted in a 3-fold increase in TNF mRNA abundance ( Figure 2B) . Similarly, TNF administered to cultured C2C12 skeletal myotubes caused a rapid increase in TNF mRNA abundance, with a 3-fold increase still apparent after 24 hours ( Figure 2C ). These data demonstrate that TNF is indeed capable of inducing its own expression in skeletal muscle.
Skeletal muscle atrophy in SP-C/TNF mice
In vitro studies have demonstrated that pro-inflammatory signaling pathways activated by TNF can cause atrophy of myotubes (20, 23) , or inhibit muscle formation (15, 24). Since the increased TNF mRNA expression observed in skeletal muscle of SP-C/TNF mice suggested that skeletal muscle of Tg+ animals responded to the elevated levels of circulating TNF , we investigated whether this was associated with a change in muscle weight. Evaluation of soleus, gastrocnemius, and plantaris muscles revealed a 9-14% reduction in the weight of these skeletal muscles of Tg+ compared to WT mice. Body weights of Tg+ animals were also reduced, whereas body and tibia length were not different between Tg+ and WT mice (Table 1) .
We next determined whether mRNA abundance of a number of muscle specific genes encoding regulatory factors, structural proteins or enzymes was affected using RNase Protection Assay (RPA) (Figure 3 ). No differences between the mRNA levels of MyoD, myogenin, Troponin-I fast, muscle creatine kinase (MCK) or myoglobin in skeletal muscle of WT and Tg+ mice could be detected ( Table 2 ), suggesting that the decreases in muscle weight are not linked to changes in mRNA expression of these muscle proteins.
Altered skeletal muscle plasticity in SP-C/TNF mice
Muscle plasticity refers to the ability of skeletal muscle to change composition or size according to functional demand. To test whether muscle atrophy observed in Tg+ mice was associated with impaired muscle plasticity, animals were subjected to a hind limb unloading (HU)/reloading (RL)
protocol. Two weeks of unloading caused a ~40% and ~20% reduction in the weight of the soleus and gastrocnemius muscle respectively in WT animals ( Figure 4A ). Although initial muscle weight was decreased in Tg+ animals, unloading caused a relative smaller reduction (34% in soleus and 11% in gastrocnemius weight, respectively) in Tg+ animals when compared to WT mice ( Figure 4A ). In fact, no difference in absolute soleus or gastrocnemius weight between WT and Tg+ animals was detected after HU; even after extending the unloading period to 28 days muscle weights were still equal (data not shown).
Impaired muscle regeneration in SP-C/TNF mice
Muscle plasticity also encompasses increases (growth) or restoration (regeneration) of muscle size, and muscle regeneration requires myoblast proliferation and differentiation (25) . To evaluate whether muscle regeneration was affected, soleus and gastrocnemius muscle weights were determined in groups of mice that were subjected to 14 days of unloading atrophy followed by 3, 5, 7, or 14 days of hind limb reloading. Compared to the weight directly following HU, which was equal in WT and SP-C/TNF mice, soleus and gastrocnemius muscle weight gain during reloading was greater in WT compared to Tg+ animals ( Figure 4B ). Figure 5A ). Interestingly, the proliferative response was stronger in WT muscle than in Tg+ muscle, and this difference was most apparent after 3 days of reloading, as His 3.2 abundance in WT muscle was increased 6-fold over control value versus a 4-fold increase in Tg+ muscle.
To evaluate myoblast differentiation during reloading, mRNA encoding perinatal myosin heavy chain (MyHC-p), a sensitive differentiation marker (27) was determined by RPA. MyHC-p mRNA abundance was not different between WT and Tg+ mice under baseline and HU conditions (data not shown). In soleus muscle of WT animals MyHC-p mRNA was induced by reloading in a time-dependent fashion, with a maximal 4-fold induction after 5 days of reloading and levels returning towards baseline after 7 and 14 days ( Figure 5B ). In contrast, the reloadinginduced increase in MyHC-p was not observed in the soleus muscles of Tg+ animals ( Figure 5B ).
To investigate whether the absence of a robust increase in MyHC-p expression during RL in Tg+ animals may be attributed to TNF action, differentiating C2C12 myoblasts were incubated with this cytokine. The accumulation of MyHC-p mRNA transcripts observed during myoblast differentiation was strongly suppressed by TNF (Figure 6 ), in support of an inhibitory role of TNF during muscle regeneration.
DISCUSSION
Besides primary organ failure and local inflammation, chronic wasting conditions such as COPD are associated with a systemic inflammatory response and skeletal muscle atrophy (5-7). In SP-C/TNF mice, which exhibit emphysematous changes (18, 28) and pulmonary inflammation (17, 18) analogous to COPD, we now demonstrate elevated levels of TNF and sTNF-RII in the circulation, and increased endogenous TNF mRNA expression in skeletal muscle, suggestive of a systemic inflammatory response. Importantly, SP-C/TNF mice exhibited decreased skeletal muscle and body weight, and impaired muscle regenerative capacity, which may contribute to skeletal muscle atrophy.
Pulmonary inflammation is a well documented feature of COPD, exemplified by local increases in levels of TNF and its receptors (4). However, the inflammatory response often extends beyond the diseased lung, as circulating levels of a number of cytokines, chemokines and their receptors are elevated in COPD (6, 7, 29) . In SP-C/TNF mice, the directed expression of the TNF transgene results in pulmonary inflammation (17, 18) . Importantly, the presence of inflammatory mediators was not restricted to the lungs of these animals, as increased levels of circulating TNF and sTNF-RII were detected. This may indicate spill-over of inflammatory mediators from the pulmonary compartment into the circulation, but since TNF and sTNF-RII levels did not correlate in BAL fluid and serum (data not shown), tissues other than the lung may have contributed to the elevated TNF and sTNF-RII levels in the serum of SP-C/TNF mice.
Skeletal muscle is capable of expressing an array of cytokines and chemokines (30) , which have mostly been studied in the context of muscle injury and repair. Analysis of various hind limb muscles of SP-C/TNF mice revealed increased TNF mRNA levels compared to control 14 animals. This increase did not concern transgenic TNF due to a leaky SP-C promoter, because our detection method for TNF mRNA was set up to discriminate between endogenous and transgenic TNF mRNA. Although in vitro studies have demonstrated that skeletal muscle is capable of TNF secretion (30) , it remains unclear whether the increased muscle TNF expression levels contribute to the raised TNF concentration in the circulation of SP-C/TNF mice. In fact, it is also conceivable that TNF expression in muscle is the consequence of the elevated circulating TNF levels, reflecting a positive feedback mechanism by which TNF binding to its receptor on the surface of myofibers stimulates its own expression in skeletal muscle. This notion is further supported by our data showing increased TNF mRNA expression in either mouse skeletal muscle following IM TNF injections, or in cultured myotubes after treatment with TNF . Still, a contribution of other circulating cytokines such as interleukin-1 and -6, which are also associated with muscle wasting to increased muscular TNF expression in skeletal muscle can not be ruled out.
SP-C/TNF mice demonstrated a reduction in body weight which may be a direct or indirect effect of the observed systemic inflammatory response. An anorexic effect of chronic inflammation can not entirely be ruled out as food intake was not determined in this study.
However, decreased food intake affects adipose tissue rather than skeletal muscle mass (31),
whereas our data clearly demonstrate a reduction in muscle mass. In addition, body and tibia length were not decreased in transgenic animals, ruling out growth retardation, either through decreased food intake or other mechanisms, as a cause of the decreased body and muscle weights of SP-C/TNF mice. The balance between muscle protein synthesis and breakdown is a major determinant whether skeletal muscle grows, atrophies or remains at constant weight (32) .
Evaluation of the mRNA abundance of a number of genes encoding muscle structural or regulatory proteins did not reveal any alterations in muscle gene expression in SP-C/TNF mice.
This suggests that decreased muscle gene expression is not responsible for inflammation-induced muscle atrophy, although the potential contribution of changes in mRNA translation efficiency can not be ruled out.
Muscle atrophy observed in SP-C/TNF mice may likely be the consequence of increased protein degradation resulting in a net loss of muscle protein. Increased muscle proteolysis has been reported in a number of non-inflammatory models of muscle atrophy and involves degradation of muscle proteins through the ubiquitin 26S-proteasome pathway (UPP) (33) (34) (35) .
Recently, an important role for NF-B was postulated in the regulation of protein degradation through the UPP during muscle atrophy, as inhibition of NF-B activation preserved muscle tissue in various experimental models of muscle atrophy (10, 36) . Conversely, constitutive activation of NF-B in skeletal muscle was sufficient to induce profound muscle atrophy via increased UPP-dependent proteolysis (10). Although we did not assess NF-B activity directly, the elevated expression levels of endogenous TNF in skeletal muscle of SP-C/TNF mice could be considered as indirect evidence of NF-B activation, since transcriptional regulation of TNF expression requires NF-B activity (37) .
Muscle regeneration following muscle damage or during recovery from atrophy requires the activation of local muscle precursor cells named satellite cells (25) . Upon activation, these cells proliferate to form a pool of myoblasts, which differentiate and fuse to myofibers, and these processes were found to be essential for efficient muscle regeneration (19) . Analysis of H3.2 mRNA abundance revealed a decreased proliferative response in soleus muscle of SP-C/TNF compared to WT mice during reloading. Although the contribution of cell types other than skeletal muscle to the H3.2 signal can not completely be ruled out, proliferation signals in regenerating muscle have clearly been associated with dividing myoblasts in other studies (38, 39) , suggesting a potential defect in myoblast proliferation in SP-C/TNF mice.
MyHC-p is a sensitive differentiation marker and its expression is positively regulated by the muscle specific transcription factor MyoD (27) . Previously, we and others have demonstrated that myogenic differentiation is inhibited by TNF in a NF-B-dependent fashion (14, 15) . In line with these findings, TNF inhibited the expression of MyHC-p in differentiating myoblasts.
Using the same in vitro model, we previously showed that inhibition of muscle gene expression by TNF was associated with decreased MyoD protein stability and abundance, with minor effects of TNF on MyoD mRNA levels (16) . Accordingly, the reduced MyHC-p transcript accumulation ( Figure 5B ) despite a similar temporal induction of MyoD mRNA levels (data not shown) in reloaded muscle of SP-C/TNF compared to wild type animals, may have resulted from MyoD protein destabilization and subsequent impaired transcriptional regulation of MyHCp by TNF .
As these data demonstrate that inhibition of myoblast differentiation by TNF is characterized by decreased MyHC-p accumulation, increased levels of TNF and/or muscular NF-B activation may be responsible for impaired myoblast differentiation and muscle regeneration in SP-C/TNF mice. Although it is currently unclear whether myoblast proliferation and differentiation are required for muscle maintenance, this study demonstrates that impaired muscle regeneration may contribute to skeletal muscle loss in disease conditions that are accompanied by chronic inflammation.
In conclusion, our results demonstrate that chronic pulmonary inflammation results in muscle atrophy and impaired muscle regeneration in SP-C/TNF mice, possibly as a consequence of an LEGENDS Table 1 : Body and muscle weight of WT and SP-C/TNF mice Body weight, muscle weight, body and tibia length were determined in WT or SP-C/TNF mice, and differences ( ) were expressed relative (%) to WT values. n=8/group; p-values were determined by 1-way ANOVA. Table 2 :
Muscle specific mRNA expression in WT and SP-C/TNF mice RNA was extracted from gastrocnemius muscle and subjected to RPA analysis to determine mRNA abundance of MyoD, myogenin, troponin I-fast, muscle creatine kinase (MCK) and myoglobin. mRNA signal intensity was normalized to GAPDH and differences ( ) were expressed relative (%) to WT values. n=7/group; n.s.: non-significant differences determined by 1-way ANOVA. Myoblasts were induced to differentiate in the presence or absence of TNF (10ng/ml) for, 24h, 48h or 72h (DM: differentiation medium). MyHC-p expression was evaluated by RPA analysis, band intensity was normalized to GAPDH, and expressed as fold increase over control (=GM; myoblasts cultured in growth medium). *: p<0.001 between sham and TNF as determined by one-way ANOVA. 
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